"Hepatitis B virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
| Descriptor ID |
D006515
|
| MeSH Number(s) |
B04.280.375.650.425 B04.450.390.650.425
|
| Concept/Terms |
Hepatitis B virus- Hepatitis B virus
- B virus, Hepatitis
- Hepatitis B viruses
- viruses, Hepatitis B
- Hepatitis Virus, Homologous Serum
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B virus".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B virus".
This graph shows the total number of publications written about "Hepatitis B virus" by people in this website by year, and whether "Hepatitis B virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 3 | 1 | 4 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 3 | 3 | 6 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 2 | 5 |
| 2008 | 2 | 2 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 6 | 3 | 9 |
| 2013 | 6 | 1 | 7 |
| 2014 | 2 | 2 | 4 |
| 2015 | 6 | 5 | 11 |
| 2016 | 3 | 2 | 5 |
| 2017 | 3 | 3 | 6 |
| 2018 | 5 | 1 | 6 |
| 2019 | 2 | 1 | 3 |
| 2020 | 6 | 1 | 7 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 6 | 7 |
| 2023 | 1 | 4 | 5 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B virus" by people in Profiles.
-
Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma. Lancet. 2024 Apr 06; 403(10434):1372-1373.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
-
Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination. Trans R Soc Trop Med Hyg. 2023 09 01; 117(9):628-636.
-
HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. Front Immunol. 2023; 14:1216610.
-
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
-
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors. Clin Lymphoma Myeloma Leuk. 2023 08; 23(8):610-615.
-
False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.
-
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int. 2023 04; 17(2):509-511.
-
Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2/S promoter activity. Antiviral Res. 2022 Dec; 208:105448.